| Catalog | name | Description | price |
|---|---|---|---|
| R-M1-8665 | Dopamine hydrochloride-r-Polyglutamic acid-L-cysteine (retained SH) | Dopamine hydrochloride-r-Polyglutamic acid-L-cysteine (retained SH) can be used drug delivery, bioconjugation, or the development of novel therapeutic agents. | price> |
| R-M2-10835 | Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31) | Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)/Liposome loaded Pemafibrate (K-877)+surface peptide targeting peg2k-PECAM-1 (CD31) is a specific targeted peptide PECAM-1 (CD31) loaded pembrolizumab (K-877) long circulating liposome nanomaterial, which belongs to the forefront of targeted delivery for cardiovascular diseases. Currently, it is only in the laboratory research stage and has no clinical products on the market. It can be used in the research of targeted treatment of atherosclerosis, vascular endothelial injury related diseases, and drug delivery system optimization. | price> |
| R-M2-10922 | SP94 peptide-liposomes@capsaicin | SP94 peptide-liposomes@capsaicin/SP94 peptide modified liposomes encapsulating capsaicin is a functional nano drug delivery system developed specifically for targeted therapy of liver cancer. It uses SP94 liver cancer specific targeting peptide modified liposomes as carriers to efficiently encapsulate the hydrophobic active ingredient capsaicin, greatly improving the tumor targeting enrichment efficiency and in vivo bioavailability of the drug. | price> |
| R-M2-10931 | Chitosan(20-50nm) nanoparticles@Catalpol surface targets peptide TGNYKALHPHNG | Chitosan(20-50nm)nanoparticles@Catalpol surface targets peptide TGNYKALHPHNG/Chitosan(20-50nm) nanoparticles loaded Catalpol surface targets peptide TGNYKALHPHNG is a functionalized chitosan nanocarrier system developed specifically for targeted delivery of central nervous system diseases. It uses narrow distribution chitosan nanoparticles at 20-50 nm as carriers, efficiently encapsulating the neuroprotective active ingredient catalpol, and surface anchoring TGNYKALHPHNG cross blood-brain barrier targeting peptides to achieve precise and efficient delivery of catalpol to brain lesions. | price> |
| R-M2-11025 | L-Cys modified BaTiO3 nanoparticles,100nm | L-Cys modified BaTiO3 nanoparticles 100nm/L-Cys modified barium titanate nanoparticles,100nm are a functionalized piezoelectric nanomaterial that not only retains the high dielectric and piezoelectric effects of barium titanate, but also introduces rich subsequent biological coupling sites through the active side chains of cysteine. It is a core customized functional nanomaterial in the fields of biomedical piezoelectric therapy and biosensing. | price> |
| R-M2-11026 | D-Cys modified BaTiO3 nanoparticles,100nm | D-Cys modified barium titanium nanoparticles, 100nm, are a chiral functionalized piezoelectric nanomaterial that fully retains the high dielectric and piezoelectric effects of barium titanate, while endowing the material with special biological interface interaction characteristics that distinguish it from L-type cysteine modified products through the unique spatial configuration of D-type chiral cysteine. It is a customized functional nanomaterial in the fields of chiral biomedical and chiral catalysis. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


